King Rachel K.

CIK 00015897123 companiesGAITHERSBURG, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001589712

Recent Transactions

50 trades

Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2025-06-26+36,000→ 36,000 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2025-06-20$6.42/sh+28,326→ 28,326 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2025-06-20+18,884→ 18,884 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2025-06-12+10,420→ 25,190 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2025-06-12−10,420→ 0 total
Sale
NOVAVAX INC$NVAX
Common Stock
2024-12-13$9.02/sh−4,150→ 14,770 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2024-11-12+60,000→ 60,000 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2024-06-12$15.86/sh+15,630→ 15,630 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2024-06-12+10,420→ 10,420 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2024-06-12+6,670→ 18,920 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2024-06-12−6,670→ 0 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Stock Option (right to buy)
2024-05-01+40,000→ 40,000 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-03-29$3.00/sh+3,334→ 515,194 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Common stock
2023-12-29$2.36/sh+4,238→ 511,860 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Common stock
2023-09-30$1.50/sh+6,667→ 507,622 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2023-06-12+7,710→ 7,710 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2023-06-12+6,670→ 6,670 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2023-06-10+3,100→ 10,050 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2023-06-10−3,100→ 0 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Stock Option (right to buy)
2023-05-19+35,000→ 35,000 total
Will/Inheritance
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2022-08-02+7,500→ 7,500 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2022-06-17−700→ 0 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2022-06-17+700→ 6,950 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2022-06-10+3,100→ 3,100 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2022-06-10+4,600→ 4,600 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Stock Option (right to buy)
2022-05-18+21,000→ 21,000 total
Will/Inheritance
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2022-02-15+11,641→ 500,955 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2021-06-25+3,450→ 6,250 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2021-06-25−3,450→ 3,450 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2021-06-25+6,900→ 9,700 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2021-06-25−6,900→ 0 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2021-06-17+1,300→ 1,300 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2021-06-17+700→ 700 total
Purchase
NOVAVAX INC$NVAX
Common Stock
2021-05-19$139.64/sh+700→ 2,800 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Employee Stock Option (right to buy)
2021-01-20+192,500→ 192,500 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2021-01-20+96,250→ 452,314 total
Exercise/Conversion
CRESCENT BIOPHARMA, INC.$CBIO
Employee Stock Option (right to buy)
2020-12-28−130,821→ 0 total
Exercise/Conversion
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2020-12-28$1.12/sh+130,821→ 440,240 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2020-12-28$3.91/sh−84,176→ 356,064 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2020-06-25+3,450→ 3,450 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to buy)
2020-06-25+6,900→ 6,900 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Employee Stock Option (right to buy)
2020-01-22+349,000→ 349,000 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to buy)
2019-12-12+18,000→ 18,000 total
Exercise/Conversion
CRESCENT BIOPHARMA, INC.$CBIO
Employee Stock Option (right to buy)
2019-08-06−166,759→ 130,821 total
Exercise/Conversion
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2019-08-06$1.12/sh+166,759→ 307,144 total
Purchase
NOVAVAX INC$NVAX
Common Stock
2019-03-27$0.53/sh+22,000→ 22,000 total
Purchase
NOVAVAX INC$NVAX
Common Stock
2019-03-27$0.53/sh+22,000→ 22,000 total
Purchase
NOVAVAX INC$NVAX
Common Stock
2019-03-27$0.53/sh+42,000→ 42,000 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Employee Stock Option (right to buy)
2019-01-17+265,000→ 265,000 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to buy)
2018-10-31+160,000→ 160,000 total

Companies

Recent Filings

Address

C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250

GAITHERSBURG, MD, 20879

View on SEC.gov